Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Growth Hormone Treatment in Growth Hormone-Sufficient and -Insufficient Children with Intrauterine Growth Retardation/Russell-Silver Syndrome

1 Jan 1998

Abstract excerpt

Fifty-eight short prepubertal children with IUGR received GH treatment (mean dose: 28 IU/m2/week) for a mean (SEM) period of time of 3.4 (0.13) years (range 1-4 years). They were subdivided according to their GH response to a pharmacological test. Twenty-six were GH insufficient (GHI) (group 1) and 32 were non-GHI (group 2). At the commencement of GH therapy mean chronological age was 6.1 (0.4) years in both...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Birth, Development, and Health
Share to Genetic Syndromes and Imprinting
Share to Renal and related cancers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 9691209
DOI: 10.1159/000023196

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Growth Hormone Treatment in Growth Hormone-Sufficient and -Insufficient Children with Intrauterine Growth Retardation/Russell-Silver SyndromePMID 9691209Read ↗

Update in growth hormone therapy of children.Semantic proximity Read ↗

Comparison of Bioinactive Growth Hormone Cases with Small for Gestational Age and Idiopathic Short Stature CasesSemantic proximity Read ↗

Achieving Optimal Short- and Long-term Responses to Paediatric Growth Hormone TherapySemantic proximity Read ↗

Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II).Semantic proximity Read ↗

Long-Term Treatment with Recombinant Insulin-Like Growth Factor (IGF)-I in Children with Severe IGF-I Deficiency due to Growth Hormone InsensitivitySemantic proximity Read ↗

The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age.Semantic proximity Read ↗

The phenotype of adults with partial growth hormone deficiency.Semantic proximity Read ↗

Short stature related to Growth Hormone Insensitivity (GHI) in childhoodSemantic proximity Read ↗

Different relationships between the first 2 years on growth hormone treatment and the d3-growth hormone receptor polymorphism in short small-for-gestational-age (SGA) childrenSemantic proximity Read ↗

Recombinant Insulin-Like Growth Factor (IGF)-I Treatment in Short Children with Low IGF-I Levels: First-Year Results from a Randomized Clinical TrialSemantic proximity Read ↗

Childhood-onset growth hormone (GH) deficiency in adult life.Semantic proximity Read ↗

Growth hormone therapy in young children with Down syndrome and a clinical comparison of Down and Prader-Willi syndromes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.